Leading authority in multiple myeloma research and treatment will co-chair PER’s legacy Winter Hematology® conference, now in its 20th year
PLAINSBORO, N.J. (August 10, 2015) — Physicians’ Education Resource®, LLC (PER®), the go-to source for oncology and hematology continuing medical education, welcomes Sagar Lonial, M.D., professor, Emory School of Medicine, executive vice chair, Department of Hematology & Medical Oncology, and chief medical officer, Winship Cancer Institute of Emory University, as co-chair of the 20th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma. The Winter Hematology® conference will be held Friday through Sunday, March 18-20, 2016, at the Eden Roc Miami Beach in Miami Beach, Fla.
For 20 years, the annual International Congress on Hematologic Malignancies® has been a prestigious gathering of medical oncologists, hematologists and other oncology healthcare professionals eager to learn about cutting-edge treatments, continually evolving standards of care and emerging clinical data that can be immediately used to improve the care of patients with hematologic malignancies. PER, the conference organizer, develops and accredits the meeting each year to provide continuing medical education for physicians.
Beginning in 2016, Dr. Lonial will join current chair Andre Goy, M.D., M.S., who is the chairman and director, lymphoma division chief, John Theurer Cancer Center at HackensackUMC, chief science officer and director of research and innovation, Regional Cancer Care Associates LLC, both in Hackensack, N.J., and professor of medicine, Georgetown University. Together, Drs. Goy and Lonial will lead the development of a clinically impactful meeting agenda that addresses the latest advances in the treatment of hematology in a format that attendees can immediately adapt for use in their practices when they return.
Considered one of the country’s leading multiple myeloma experts, Dr. Lonial is working to transform the treatment of hematology with his leadership in the investigation of novel agents, including monoclonal antibodies, which represent an entirely new class of therapy.
“I am honored to join Dr. Goy as co-chair of this historic annual meeting,” Dr. Lonial said. “I am excited to share in the development of next year’s impactful event, discuss the many new treatment options that are emerging in care and provide an unparalleled educational experience for attendees.”
During the congress, Drs. Goy and Lonial will join a faculty of other leaders in cutting-edge research, treatment and management who are delivering presentations, sharing cases and discussing best practices that focus on the various treatment situations encountered by oncologists and hematologists. Over the course of the three days, the expert faculty will distill data and highlight critical information that will enhance and inform treatment approaches for patients affected by various subtypes of hematologic malignancies, with a focus on lymphomas, leukemias and myeloma.
This educational congress will be impactful for medical oncologists and hematologists as well as fellows, nurse practitioners, nurses, pharmacists, researchers and other healthcare professionals interested in the treatment of hematologic malignancies., PER incorporates instructional design with principles of adult learning as it plans, develops, implements and evaluates many educational opportunities each year, including 10 well-known and respected legacy annual national conferences. These educational activities enable healthcare professionals to remain current with and responsive to advances in medical care for cancer patients, from diagnosis through treatment, with the ultimate goal of improving patient outcomes.
“Dr. Lonial’s expertise will enhance conference discussions, especially those focused on therapy combinations in multiple myeloma, a treatment area that is currently expanding at an unprecedented pace,” said Phil Talamo, PER’s vice president, independent medical education & operations. “We know that having Dr. Lonial share practical expertise along with relevant and applicable patient cases will benefit physicians and others striving to provide the best care possible for patients. We are excited that Dr. Lonial will join nationally recognized lymphoma expert Dr. Goy as co-chair of our historic hematology meeting, and we know that together they will ensure a first-class educational experience.”
To register for the 20th Annual International Congress on Hematologic Malignancies® or to view more information about the meeting, please visit www.gotoper.com.
Accredited by the Accreditation Council for Continuing Medical Education, PER is the “go-to” resource for live and online activities focusing on oncology and hematology. PER provides high‑quality, evidence-based CME-certified activities featuring leading national and international faculty with a focus on practice-changing advances and standards of care in treatment and disease management. These activities also include topics on emerging strategies currently under investigation, supportive care, diagnosis and staging, prevention, screening and early detection, and practice management. PER serves the oncology healthcare community, including physicians, nurses, nurse practitioners, physician assistants and pharmacists. PER is part of the Plainsboro, N.J.-based Michael J. Hennessy Associates, Inc. (MJH) family of businesses. Learn more at www.gotoper.com and www.mjhassoc.com.
Media Contacts for PER:
Becky Taylor, 609-240-6886, firstname.lastname@example.org
Robert Walker, 609-378-3730, email@example.com
PressBack to Press
Sagar Lonial, MD, Joins Andre Goy, MD, MS, To Co-Chair PER's Historic International Congress On Hematologic Malignancies® In 2016
Back to Press